New drug reverses even 'untreatable' cancers

Read entire article here:

" Dr Brad Thompson, president and chief executive of Oncolytics Biotech Inc, the Canadian manufacturers of Reolysin, said: ''We believe that this study clearly demonstrates that the combination of low dose radiation and Reolysin is well tolerated and that the very high response rate warrants further investigation.''

No comments:

Post a Comment

Only by exercising YOUR freedom of speech shall you keep it. Comment now - I can handle it....

Note: Only a member of this blog may post a comment.